Useful statistics and facts included in the 2011 Progress Report
- Collaborating with Coca-Cola in Ghana
Collaborating with Coca-Cola in Ghana
The Coca-Cola Company, the world’s largest beverage company, is working with the Bill & Melinda Gates Foundation, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and GAVI to find ways to strengthen Ghana’s vaccine supply chain by sharing Coca-Cola’s unparalleled distribution and logistical expertise to ensure that vaccines are delivered to “the last mile.” In addition, the Ministry of Health will be able to tap into Coca-Cola’s marketing expertise to boost awareness of and participation in vaccine campaigns.
- Donor reviews
Donor reviews give top scores to GAVI
Two donors released reviews of GAVI’s performance in 2011. The UK undertook a detailed review of multilateral aid, assessing the effectiveness of over 40 multilateral organisations in tackling poverty. Its conclusions endorsed both the value of immunisation and GAVI’s organisational strengths. Sweden also conducted a review of GAVI in 2011, giving top marks to the organisation for relevance and effectiveness.
- G8 fact
According to a G8 study, which calculated the proportion of donor support that directly benefits maternal and child health, 100% of contributions to GAVI reach mothers and children in the developing world. Governments donating to GAVI are thus assured that their commitments will help meet the goals set out in the G8 Muskoka Initiative.
- How vaccines work
How vaccines work
Each child is born with a natural immune system which protects against disease-causing agents, such as bacteria and viruses. When such an agent – or antigen – enters the body, the immune system produces antibodies to destroy it. once our immune system has been exposed to a particular antigen, it “remembers” it and can defend against it in the future.
Vaccines contain inactivated or greatly weakened versions of the antigens (or parts of the antigens) that are responsible for disease. the antigens in vaccines are not strong enough to cause illness, but they prime the immune system to recognise a particular antigen and to mount an appropriate immune response.
- Vaccines key to cancer prevention
Vaccines key to cancer prevention
Almost 20% of all cancer cases are caused by chronic infections. Hepatitis B is a leading cause of liver cancer, while human papillomavirus (HPV) infection is responsible for virtually all cases of cervical cancer. GAVI is directly supporting the introduction of safe and effective vaccines that can protect millions from these two leading cancers.
Working with Vodafone
GAVI is working with Vodafone, one of the world’s leading communications companies, to explore the use of mobile (“mHealth”) technologies to improve vaccine stock management in implementing countries. This collaboration was initiated following a meeting among Vodafone CEO Vittorio Colao, the UK Secretary of State for International Development Andrew Mitchell and GAVI CEO Seth Berkley.
- Why DTP3?
DPT3 coverage is considered the best indicator of the reach of national immunisation programmes.
A fully-functioning immunisation system – comprising a well-trained work force, robust vaccine supply and distribution systems, and strong management and monitoring functions – is essential to immunising children with three doses of DTP at the recommended 6-, 10- and 14-week intervals. The vast majority of children in GAVI-supported countries receive DTP as part of the pentavalent vaccine, which also includes antigens against hepatitis B and Hib.
- 1-in-5 fact
1 in 5
CHILDREN MISSES OUT ON LIFE-SAVING VACCINES EVERY YEAR
- Best buy fact
VACCINES ARE ONE OF THE “BEST BUYS” IN PUBLIC HEALTH, OFTEN COST-SAVING IN THE LONG RUN THROUGH REDUCTIONS IN HEALTHCARE EXPENSES
- Cervical cancer fact
7 out of 10
CERVICAL CANCER CASES CAN BE PREVENTED WITH HPV VACCINES
- Co-financing fact
93% of countries
IN 2011, 93% OF COUNTRIES REQUIRED TO CO-FINANCE MET THEIR COMMITMENTS
- DTP3 vaccine fact
DTP3 VACCINE COVERAGE IN 72 GAVI-ELIGIBLE COUNTRIES REACHED A RECORD HIGH OF 81% IN 2011
- Hepatitis B
WITH SUPPORT FROM GAVI 296 MILLION CHILDREN HAVE BEEN IMMUNISED AGAINST HEPATITIS B
- Hepatitis B fact
BETWEEN 2000 AND 2011, THE PRICE OF HEPATITIS B VACCINE DROPPED BY 69%
- IFFIm fact
A 2011 INDEPENDENT EVALUATION OF IFFIM FOUND THAT IT HAD YIELDED EXTREMELY GOOD DEVELOPMENT RETURNS
- Meningitis A fact
Only 4 cases
OF MENINGITIS A WERE REPORTED IN BURKINA FASO IN THE 2010–2011 EPIDEMIC SEASON – ALL IN UNIMMUNISED PEOPLE
- Pneumo fact
10 million children
IN DEVELOPING COUNTRIES WILL BE IMMUNISED WITH PNEUMOCOCCAL VACCINES IN 2012
- Price reductions fact
MANUFACTURERS HAVE OFFERED TWO-THIRDS PRICE REDUCTIONS ON HPV AND ROTAVIRUS VACCINES
- Rota fact
8 out of 10
BY THE TIME THEY ARE 18 MONTHS, 8 OUT OF 10 AFRICAN CHILDREN WILL HAVE CONTRACTED ROTAVIRUS
Over 20 countries
WILL SOON HAVE ROLLED OUT ROTAVIRUS VACCINE WITH GAVI SUPPORT
- Rotavirus fact
6 out of 10
IN NICARAGUA, THE FIRST GAVI-ELIGIBLE COUNTRY TO INTRODUCE ROTAVIRUS VACCINES, 6 OUT OF 10 SEVERE CASES OF LIFE-THREATENING DIARRHOEA WERE PREVENTED.
- Rubella fact
9 out of 10
PREGNANT WOMEN WITH RUBELLA WILL TRANSMIT THE DISEASE TO THEIR UNBORN CHILD
- Vaccine preventable fact
Every 60 seconds
THREE CHILDREN DIE OF A VACCINE-PREVENTABLE DISEASE
- Yellow fever fact
14 million people
WERE IMMUNISED THROUGH GAVI-SUPPORTED VACCINE CAMPAIGNS AGAINST YELLOW FEVER IN 2011